[go: up one dir, main page]

NO20004722D0 - Faste, hurtigdesintegrerende cetirizin-formuleringer - Google Patents

Faste, hurtigdesintegrerende cetirizin-formuleringer

Info

Publication number
NO20004722D0
NO20004722D0 NO20004722A NO20004722A NO20004722D0 NO 20004722 D0 NO20004722 D0 NO 20004722D0 NO 20004722 A NO20004722 A NO 20004722A NO 20004722 A NO20004722 A NO 20004722A NO 20004722 D0 NO20004722 D0 NO 20004722D0
Authority
NO
Norway
Prior art keywords
disintegrating
fast
solid
cetirizine formulations
cetirizine
Prior art date
Application number
NO20004722A
Other languages
English (en)
Other versions
NO329071B1 (no
NO20004722L (no
Inventor
Wolfram Tritthart
Mario Andre Piskernig
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20004722D0 publication Critical patent/NO20004722D0/no
Publication of NO20004722L publication Critical patent/NO20004722L/no
Publication of NO329071B1 publication Critical patent/NO329071B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20004722A 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer NO329071B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (3)

Publication Number Publication Date
NO20004722D0 true NO20004722D0 (no) 2000-09-21
NO20004722L NO20004722L (no) 2000-09-21
NO329071B1 NO329071B1 (no) 2010-08-16

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004722A NO329071B1 (no) 1998-03-31 2000-09-21 Faste, hurtig desintegrerende cetirizin-formuleringer

Country Status (30)

Country Link
US (1) US6245353B1 (no)
EP (1) EP1067904B1 (no)
JP (1) JP2002509873A (no)
KR (1) KR100653568B1 (no)
CN (1) CN1136838C (no)
AR (1) AR018828A1 (no)
AT (1) ATE209899T1 (no)
AU (1) AU750140B2 (no)
BG (1) BG64741B1 (no)
BR (1) BR9909233A (no)
CA (1) CA2326809C (no)
CY (1) CY1107331T1 (no)
CZ (1) CZ300704B6 (no)
DE (2) DE19814256A1 (no)
DK (1) DK1067904T3 (no)
ES (1) ES2168013T3 (no)
HU (1) HU227477B1 (no)
IL (1) IL138606A (no)
NO (1) NO329071B1 (no)
NZ (1) NZ506988A (no)
PL (1) PL191266B1 (no)
PT (1) PT1067904E (no)
RU (1) RU2216318C2 (no)
SI (1) SI1067904T1 (no)
SK (1) SK284476B6 (no)
TR (1) TR200002809T2 (no)
TW (1) TWI233808B (no)
UA (1) UA57615C2 (no)
WO (1) WO1999049843A1 (no)
ZA (1) ZA200005134B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302201A4 (en) 2000-07-17 2007-09-05 Astellas Pharma Inc PHARMACEUTICAL COMPOSITION WITH IMPROVED ABSORBABILITY
CA2472396A1 (en) * 2002-01-15 2003-07-24 Ucb Farchim, S.A. Formulations
CA2481025A1 (en) * 2002-04-04 2003-10-16 Tanya Havlir Palatable chewable tablet
CA2566384C (en) * 2004-05-28 2010-08-03 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
LT2486942T (lt) 2004-11-24 2019-01-25 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
EP3449928A1 (en) 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
CA2734691C (en) * 2008-09-05 2017-05-16 Mcneil-Ppc, Inc. Method for making cetirizine tablets
CA2755543A1 (en) * 2009-03-13 2010-09-16 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of cardiovascular disease
WO2011146032A2 (en) * 2010-05-18 2011-11-24 Mahmut Bilgic Effervescent formulations
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CA2876062C (en) 2012-06-12 2017-09-12 The Procter & Gamble Company Effervescent dosage form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI732337B (zh) * 2014-06-20 2021-07-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
WO2021156698A1 (en) * 2020-02-03 2021-08-12 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
ATE195417T1 (de) * 1991-05-13 2000-09-15 Boots Co Plc Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
DE59400446D1 (de) * 1993-04-15 1996-08-29 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
CN1122103A (zh) * 1993-04-30 1996-05-08 普罗克特和甘保尔公司 包衣药剂组合物
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
SK284476B6 (sk) 2005-04-01
HUP0102676A3 (en) 2002-12-28
DE19814256A1 (de) 1999-10-07
NZ506988A (en) 2002-05-31
BG64741B1 (bg) 2006-02-28
HUP0102676A2 (hu) 2001-11-28
CA2326809C (en) 2008-11-18
HK1036217A1 (en) 2001-12-28
CA2326809A1 (en) 1999-10-07
EP1067904B1 (de) 2001-12-05
EP1067904A1 (de) 2001-01-17
TR200002809T2 (tr) 2000-12-21
IL138606A0 (en) 2001-10-31
UA57615C2 (uk) 2003-06-16
CZ300704B6 (cs) 2009-07-22
ZA200005134B (en) 2000-12-21
NO329071B1 (no) 2010-08-16
AU3925399A (en) 1999-10-18
JP2002509873A (ja) 2002-04-02
ES2168013T3 (es) 2002-05-16
KR100653568B1 (ko) 2006-12-05
IL138606A (en) 2005-07-25
RU2216318C2 (ru) 2003-11-20
KR20010034718A (ko) 2001-04-25
BG104843A (en) 2001-07-31
DE59900501D1 (de) 2002-01-17
SK14312000A3 (sk) 2001-07-10
CZ20003481A3 (en) 2001-05-16
US6245353B1 (en) 2001-06-12
CN1136838C (zh) 2004-02-04
CY1107331T1 (el) 2012-12-19
TWI233808B (en) 2005-06-11
SI1067904T1 (en) 2002-04-30
ATE209899T1 (de) 2001-12-15
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
CN1295464A (zh) 2001-05-16
BR9909233A (pt) 2000-11-28
AR018828A1 (es) 2001-12-12
PL343199A1 (en) 2001-07-30
WO1999049843A1 (de) 1999-10-07
PL191266B1 (pl) 2006-04-28
HU227477B1 (en) 2011-07-28
AU750140B2 (en) 2002-07-11
DK1067904T3 (da) 2002-04-02

Similar Documents

Publication Publication Date Title
NO20004722L (no) Faste, hurtigdesintegrerende cetirizin-formuleringer
TR199901077A3 (tr) Ispençiyari formülasyonlar.
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
NO20004240L (no) Formuleringer
ATE224703T1 (de) Brauseformulierungen
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
ATE275557T1 (de) 2-substituierte 4,5-diarylimidazole
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT1130966E (pt) Formulacoes antiparasitarias
IS6398A (is) Lyfjablöndur
PT1210349E (pt) Pirazolo-¬4,3-d|-pirimidinas
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ATE234839T1 (de) 4,5-azolo-oxindole
DE60014639D1 (de) Riechstoffe
DE69908356D1 (de) Riechstoffe
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
ES1042496Y (es) "pilona sumible".
ITRM20000199A0 (it) Formulazione.
ES1041849Y (es) Almohada perfeccionada.
ES1040381Y (es) Almohada perfeccionada.
ES1039752Y (es) Almohada perfeccionada.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees